BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9610790)

  • 1. Strategies for recruitment to a population-based lung cancer prevention trial: the CARET experience with heavy smokers. Beta-Carotene and Retinol Efficacy Trial.
    Goodman GE; Valanis B; Meyskens FL; Williams JH; Metch BJ; Thornquist MD; Omenn GS
    Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):405-12. PubMed ID: 9610790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with cigarette smokers.
    Goodman GE; Omenn GS; Thornquist MD; Lund B; Metch B; Gylys-Colwell I
    Cancer Epidemiol Biomarkers Prev; 1993; 2(4):389-96. PubMed ID: 8348063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers.
    Omenn GS; Goodman G; Thornquist M; Grizzle J; Rosenstock L; Barnhart S; Balmes J; Cherniack MG; Cullen MR; Glass A
    Cancer Res; 1994 Apr; 54(7 Suppl):2038s-2043s. PubMed ID: 8137335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with asbestos-exposed workers.
    Omenn GS; Goodman GE; Thornquist MD; Rosenstock L; Barnhart S; Gylys-Colwell I; Metch B; Lund B
    Cancer Epidemiol Biomarkers Prev; 1993; 2(4):381-7. PubMed ID: 8348062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements.
    Goodman GE; Thornquist MD; Balmes J; Cullen MR; Meyskens FL; Omenn GS; Valanis B; Williams JH
    J Natl Cancer Inst; 2004 Dec; 96(23):1743-50. PubMed ID: 15572756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between participant characteristics and serum concentrations of beta-carotene, retinol, retinyl palmitate, and alpha-tocopherol among participants in the Carotene and Retinol Efficacy Trial (CARET) for prevention of lung cancer.
    Goodman GE; Thornquist M; Kestin M; Metch B; Anderson G; Omenn GS
    Cancer Epidemiol Biomarkers Prev; 1996 Oct; 5(10):815-21. PubMed ID: 8896893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial.
    Goodman GE; Schaffer S; Omenn GS; Chen C; King I
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):518-26. PubMed ID: 12814997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
    Spitz MR; Barnett MJ; Goodman GE; Thornquist MD; Wu X; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease.
    Omenn GS; Goodman GE; Thornquist MD; Balmes J; Cullen MR; Glass A; Keogh JP; Meyskens FL; Valanis B; Williams JH; Barnhart S; Hammar S
    N Engl J Med; 1996 May; 334(18):1150-5. PubMed ID: 8602180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in cholesterol and triglyceride concentrations in the Vanguard population of the Carotene and Retinol Efficacy Trial (CARET).
    Cartmel B; Dziura J; Cullen MR; Vegso S; Omenn GS; Goodman GE; Redlich CA
    Eur J Clin Nutr; 2005 Oct; 59(10):1173-80. PubMed ID: 16015255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of lung cancers: lessons from CARET, the beta-carotene and retinol efficacy trial, and prospects for the future.
    Omenn GS
    Eur J Cancer Prev; 2007 Jun; 16(3):184-91. PubMed ID: 17415088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprevention of lung cancer: the beta-Carotene and Retinol Efficacy Trial (CARET) in high-risk smokers and asbestos-exposed workers.
    Omenn GS; Goodman G; Thornquist M; Barnhart S; Balmes J; Cherniack M; Cullen M; Glass A; Keogh J; Liu D; Meyskens F; Perloff M; Valanis B; Williams J
    IARC Sci Publ; 1996; (136):67-85. PubMed ID: 8791118
    [No Abstract]   [Full Text] [Related]  

  • 13. Prediagnostic levels of serum beta-cryptoxanthin and retinol predict smoking-related lung cancer risk in Shanghai, China.
    Yuan JM; Ross RK; Chu XD; Gao YT; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):767-73. PubMed ID: 11440962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of supplementation with beta-carotene and vitamin A on lung nutrient levels.
    Redlich CA; Blaner WS; Van Bennekum AM; Chung JS; Clever SL; Holm CT; Cullen MR
    Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):211-4. PubMed ID: 9521435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial.
    Omenn GS; Goodman GE; Thornquist MD; Balmes J; Cullen MR; Glass A; Keogh JP; Meyskens FL; Valanis B; Williams JH; Barnhart S; Cherniack MG; Brodkin CA; Hammar S
    J Natl Cancer Inst; 1996 Nov; 88(21):1550-9. PubMed ID: 8901853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surrogate end-point biomarker analysis in a retinol chemoprevention trial in current and former smokers with bronchial dysplasia.
    Lam S; Xu X; Parker-Klein H; Le Riche JC; Macaulay C; Guillaud M; Coldman A; Gazdar A; Lotan R
    Int J Oncol; 2003 Dec; 23(6):1607-13. PubMed ID: 14612933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spirometry, rapid FEV1 decline, and lung cancer among asbestos exposed heavy smokers.
    Chien JW; Au DH; Barnett MJ; Goodman GE
    COPD; 2007 Dec; 4(4):339-46. PubMed ID: 18027161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fruits and vegetables are associated with lower lung cancer risk only in the placebo arm of the beta-carotene and retinol efficacy trial (CARET).
    Neuhouser ML; Patterson RE; Thornquist MD; Omenn GS; King IB; Goodman GE
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):350-8. PubMed ID: 12692110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CARET, the beta-carotene and retinol efficacy trial to prevent lung cancer in high-risk populations.
    Omenn GS
    Public Health Rev; 1991-1992; 19(1-4):205-8. PubMed ID: 1844268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers: a meta-analysis and evaluation of national brands.
    Tanvetyanon T; Bepler G
    Cancer; 2008 Jul; 113(1):150-7. PubMed ID: 18429004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.